General form of registration statement for all companies including face-amount certificate companies

10. Segment and Geographic Information

v2.4.1.9
10. Segment and Geographic Information
 6 Months Ended 12 Months Ended
Sep. 30, 2014
Mar. 31, 2014
Segment Reporting [Abstract]    
Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

The Company operates a single segment business for product sales, which consists of three geographical sales territories as follows (in thousands):

 

    Three Months     Six Months  
    Ended     Ended  
    September 30,     September 30,  
    2014     2013     2014     2013  
U.S.   $ 978,000     $ 1,898,000     $ 2,006,000     $ 3,221,000  
Mexico     1,541,000       1,352,000       3,011,000       2,776,000  
Europe and Rest of World     554,000       603,000       1,226,000       1,010,000  
    $ 3,073,000     $ 3,853,000     $ 6,243,000     $ 7,007,000  

 

For the three months ended September 30, 2014 and 2013, the Company received licensing revenues of $378,000 and $397,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned. For the six months ended September 30, 2014 and 2013, the Company received licensing revenues of $752,000 and $830,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned.

 

The Company’s service revenues amounted to $191,000 and $236,000 for the three months ended September 30, 2014 and 2013, respectively, and the Company’s service revenues amounted to $413,000 and $454,000 for the six months ended September 30, 2014 and 2013, respectively.

The Company generates product revenues from wound care products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers.

 

The Company operates a single segment business for product sales which consists of three geographical sales territories as follows:

 

    March 31,  
    2014     2013  
U.S.   $ 5,340,000     $ 6,842,000  
Mexico     5,259,000       5,886,000  
Europe and other     2,124,000       1,855,000  
    $ 12,723,000     $ 14,583,000  

 

For the year ended March 31, 2014 and 2013, the Company recognized product licensing revenues of $1,829,000 and $1,686,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned.

 

The Company’s service revenues amounted to $945,000 and $869,000 for the years ended March 31, 2014 and 2013.